New combo therapy aims to restore color to stubborn white skin patches
NCT ID NCT07352293
Summary
This study is testing if taking the drug methotrexate for six months improves the results of a skin cell transplant for adults with stable vitiligo that hasn't responded to other treatments. Researchers will compare two groups: one gets the transplant plus methotrexate, and the other gets the transplant alone. The goal is to see if the combination leads to better and more lasting repigmentation of white patches on the elbows and knees.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VITILIGO are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Dermatology Outpatient Clinic, Kasr al Ainy Teaching Hospital, Cairo University
RECRUITINGCairo, Egypt
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.